Long-Term Tolerance to Factor VIII Is Achieved by Administration of Interleukin-2/Interleukin-2 Monoclonal Antibody Complexes and Low Dosages of Factor VIII
Journal of Thrombosis and Haemostasis - United Kingdom
doi 10.1111/jth.12576
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2014
Authors
Publisher
Wiley